Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial (Q43624578)

From Wikidata

Jump to navigation Jump to search

scientific article published in January 2001

Language	Label	Description	Also known as
English	Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial	scientific article published in January 2001

Statements

scholarly article

1 reference

Europe PubMed Central

25 November 2017

Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial (English)

1 reference

Europe PubMed Central

25 November 2017

0 references

author name string

M G Franzosi

1

1 reference

Europe PubMed Central

25 November 2017

M Brunetti

2

1 reference

Europe PubMed Central

25 November 2017

R Marchioli

3

1 reference

Europe PubMed Central

25 November 2017

R M Marfisi

4

1 reference

Europe PubMed Central

25 November 2017

G Tognoni

5

1 reference

Europe PubMed Central

25 November 2017

F Valagussa

6

1 reference

Europe PubMed Central

25 November 2017

GISSI-Prevenzione Investigators

7

1 reference

Europe PubMed Central

25 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

25 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

25 November 2017

19

1 reference

Europe PubMed Central

25 November 2017

411-420

1 reference

Europe PubMed Central

25 November 2017

4

1 reference

Europe PubMed Central

25 November 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200119040-00008

0 references

[Pharmacoeconomic evaluation of pravastatin in the secondary prevention of coronary heart disease in patients with average cholesterol levels. An analysis for Germany based on the CARE study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-minimization and the number needed to treat in uncomplicated hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omega-3 fatty acids in health and disease and in growth and development

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-Effectiveness Analysis of Early Lisinopril Use in Patients With Acute Myocardial Infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relative risk reduction versus number needed to treat as measures of lipid-lowering trial results

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Omega-3 fatty acids in the prevention-management of cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinician's guide to cost-effectiveness analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The composition of food consumed by Greenland Eskimos.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of cholesterol-related interventions in general practice. An appraisal of the evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness analysis: are the outputs worth the inputs?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economics notes: handling uncertainty in economic evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomic analyses: making them transparent, making them credible

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Problems of using modelling in the economic evaluation of health care

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strategies for the management of hypercholesterolaemia: a systematic review of the cost-effectiveness literature.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GISSI-Prevenzione trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Explanatory and pragmatic attitudes in therapeutical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Raising the quality of cost-utility analyses: lessons learnt and still to learn

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico]

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limits to rationality: economics, economists and priority setting

1 reference

https://pubmed.ncbi.nlm.nih.gov/11383757

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200119040-00008

1 reference

Europe PubMed Central

25 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43624578&oldid=2101956823"